{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:56:05Z","timestamp":1792425365001,"version":"4.5.0"},"reference-count":73,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:p>Microbiota colonization begins at birth and continuously reshapes throughout the course of our lives, resulting in tremendous interindividual heterogeneity. Given that the gut microbiome, similar to the liver, houses many categories of catalytic enzymes, there is significant value in understanding drug-bacteria interactions. The discovery of this link could enhance the therapeutic value of drugs that would otherwise have a limited or perhaps detrimental effect on patients. Resistant hypertension is one such subset of the hypertensive population that poorly responds to antihypertensive medications, resulting in an increased risk for chronic cardiovascular illnesses and its debilitating effects that ultimately have a detrimental impact on patient quality of life. We recently demonstrated that the gut microbiota is involved in the metabolism of antihypertensive drugs and thus contributes to the pathophysiology of resistant hypertension. Due to a lack of knowledge of the mechanisms, novel therapeutic approaches that account for the gut microbiota may allow for better therapeutic outcomes in resistant hypertension. Therefore, the purpose of this review is to summarize our current, albeit limited, understanding of how the gut microbiota may possess particular enzymatic activities that influence the efficacy of antihypertensive drugs.<\/jats:p>","DOI":"10.1161\/hypertensionaha.122.19826","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T18:00:59Z","timestamp":1662573659000},"page":"2138-2147","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":34,"title":["Resistance to Antihypertensive Drugs: Is Gut Microbiota the Missing Link?"],"prefix":"10.1161","volume":"79","author":[{"given":"Jun","family":"Kyoung","sequence":"first","affiliation":[{"name":"Department of Physiology and Pharmacology, UT Microbiome Consortium, Center for Hypertension and Precision Medicine, College of Medicine and Life Sciences, University of Toledo, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit R.","family":"Atluri","sequence":"additional","affiliation":[{"name":"Department of Physiology and Pharmacology, UT Microbiome Consortium, Center for Hypertension and Precision Medicine, College of Medicine and Life Sciences, University of Toledo, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4182-9793","authenticated-orcid":true,"given":"Tao","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Physiology and Pharmacology, UT Microbiome Consortium, Center for Hypertension and Precision Medicine, College of Medicine and Life Sciences, University of Toledo, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYP.0000000000000066"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.37.4.1053"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/jhh.2013.48"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.114.03617"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.08.036"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.118.12191"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2015.06.033"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.118.313221"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1560-1"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2012.00094"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1152\/physiolgenomics.00136.2014"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.115.05315"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-016-0222-x"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/bph.14965"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1152\/physiolgenomics.00081.2016"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2020.1854642"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12489-0"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2018.01.019"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14177-z"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2015.102"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms7010014"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aag2770"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/bs.pmbts.2020.04.002"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9343(70)80129-2"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpx085"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.3390\/ph7020207"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1080\/00498250802651984"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1039\/c2dt31833d"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra032424"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.2133\/dmpk.22.96"},{"key":"e_1_3_3_32_2","first-page":"1121","article-title":"The nifedipine-rifampin interaction. Evidence for induction of gut wall metabolism.","volume":"24","author":"Holtbecker N","year":"1996","unstructured":"Holtbecker, N, Fromm, MF, Kroemer, HK, Ohnhaus, EE, Heidemann, H. The nifedipine-rifampin interaction. Evidence for induction of gut wall metabolism. Drug Metab Dispos. 1996;24:1121\u20131123.","journal-title":"Drug Metab Dispos"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.hyp.5.4_pt_2.ii18"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000000773"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.113.055400"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1177\/0300060518788994"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1985.tb05141.x"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1248\/yakushi1947.106.8_698"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1291-3"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199039050-00009"},{"key":"e_1_3_3_41_2","first-page":"612","article-title":"The anaerobic metabolism of verapamil in rat cecal contents forms nor-verapamil and thiocyanate.","volume":"254","author":"Koch RL","year":"1990","unstructured":"Koch, RL, Palicharla, P. The anaerobic metabolism of verapamil in rat cecal contents forms nor-verapamil and thiocyanate. J Pharmacol Exp Ther. 1990;254:612\u2013615.","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1999.00923.x"},{"key":"e_1_3_3_43_2","first-page":"451","article-title":"Metabolism of foreign compounds by gastrointestinal microorganisms.","volume":"25","author":"Scheline RR","year":"1973","unstructured":"Scheline, RR. Metabolism of foreign compounds by gastrointestinal microorganisms. Pharmacol Rev. 1973;25:451\u2013523.","journal-title":"Pharmacol Rev"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510240407"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0070330"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00169164"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-10346-6"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-7176.2011.00515.x"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.5009\/gnl16478"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.20524\/aog.2017.0178"},{"key":"e_1_3_3_51_2","first-page":"958","article-title":"Metabolism of carvedilol in dogs, rats, and mice.","volume":"26","author":"Schaefer WH","year":"1998","unstructured":"Schaefer, WH, Politowski, J, Hwang, B, Dixon, F, Jr, Goalwin, A, Gutzait, L, Anderson, K, DeBrosse, C, Bean, M, Rhodes, GR. Metabolism of carvedilol in dogs, rats, and mice. Drug Metab Dispos. 1998;26:958\u2013969.","journal-title":"Drug Metab Dispos"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2008.07.005"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemosphere.2017.05.088"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ibiod.2017.12.005"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1099-081x(199708)18:6<543::aid-bdd52>3.0.co;2-f"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-019-2745-x"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2006.pto_379.x"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32317-7"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.010721"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.120.14736"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-022-00921-4"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.121.18711"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.118.11064"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000203771.24792.bf"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2012.260"},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40203-020-00056-9"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.2174\/1381612820666141024151119"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.2174\/138161209788168173"},{"key":"e_1_3_3_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2015.07.078"},{"key":"e_1_3_3_70_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202001532R"},{"key":"e_1_3_3_71_2","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.201900616"},{"key":"e_1_3_3_72_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.024545"},{"key":"e_1_3_3_73_2","doi-asserted-by":"publisher","DOI":"10.1111\/apha.13256"},{"key":"e_1_3_3_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.09.058"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/HYPERTENSIONAHA.122.19826","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T10:24:58Z","timestamp":1715595898000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/HYPERTENSIONAHA.122.19826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":73,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["10.1161\/HYPERTENSIONAHA.122.19826"],"URL":"https:\/\/doi.org\/10.1161\/hypertensionaha.122.19826","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"2022-07-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}